biological source
rabbit
antibody form
purified antibody
antibody product type
primary antibodies
clone
polyclonal
form
liquid
does not contain
preservative
species reactivity
human, rat
manufacturer/tradename
Calbiochem®
storage condition
OK to freeze, avoid repeated freeze/thaw cycles
isotype
IgG
shipped in
wet ice
storage temp.
−20°C
target post-translational modification
unmodified
Quality Level
Gene Information
human ... FGF2(2247)
General description
Anti-FGF, Basic (Ab-2) (40-63), rabbit polyclonal, recognizes the ~18 kDa bFGF protein in fetal liver and kidney. It is validated for Western blotting an immunohistochemistry (paraffin sections).
Purified rabbit polyclonal antibody (see application references). Recognizes the ~18 kDa bFGF protein.
Recognizes the ~18 kDa bFGF protein in fetal liver and kidney tissue.
Immunogen
Human
a synthetic peptide (GFFLRIHPDGRVDGVREKSDPHIK) corresponding to amino acids 40-63 of human bFGF
Application
Immunoblotting (1-5 µg/ml)
Paraffin Sections (1-5 µg/ml, no pre-treatment required)
Paraffin Sections (1-5 µg/ml, no pre-treatment required)
Packaging
Please refer to vial label for lot-specific concentration.
Physical form
In 50 mM PBS, 50% glycerol.
Preparation Note
Following initial thaw, aliquot and freeze (-20°C).
Analysis Note
Positive Control
Fetal liver or kidney tissue
Fetal liver or kidney tissue
Other Notes
Antibody should be titrated for optimal results in individual systems.
Burton, P.B.J., et al. 1993. Int. J. Exp. Path.74, 87.
Fiege, J.J. and Baird, A. 1989. Proc. Natl. Acad. Sci.86, 3174.
Florkiewicz, R.Z. and Sommer, A. 1989. Proc. Natl. Acad. Sci.86, 3978.
Rifkin, D.B. and Moscatelli, D. 1989. J. Cell Biol.109, 1.
Baird, A., et al. 1988. Proc. Natl. Acad. Sci.85, 2324.
Chodak, G.W., et al. 1988. Cancer Res. 48, 2083.
Sommer, A., et al. 1987. Res. Comm.144, 543.
Abraham, J.A., et al.1986. EMBO J.5, 2523.
Esch, F., et al.1985. Proc. Natl. Acad. Sci.82, 6507.
Knighton, D., et al. 1977. Br. J. Cancer35, 347.
Fiege, J.J. and Baird, A. 1989. Proc. Natl. Acad. Sci.86, 3174.
Florkiewicz, R.Z. and Sommer, A. 1989. Proc. Natl. Acad. Sci.86, 3978.
Rifkin, D.B. and Moscatelli, D. 1989. J. Cell Biol.109, 1.
Baird, A., et al. 1988. Proc. Natl. Acad. Sci.85, 2324.
Chodak, G.W., et al. 1988. Cancer Res. 48, 2083.
Sommer, A., et al. 1987. Res. Comm.144, 543.
Abraham, J.A., et al.1986. EMBO J.5, 2523.
Esch, F., et al.1985. Proc. Natl. Acad. Sci.82, 6507.
Knighton, D., et al. 1977. Br. J. Cancer35, 347.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Standard Handling (A)
未找到合适的产品?
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 1
Frederique M D Tholozan et al.
Molecular biology of the cell, 18(11), 4222-4231 (2007-08-19)
The lens is an avascular tissue, separated from the aqueous and vitreous humors by its own extracellular matrix, the lens capsule. Here we demonstrate that the lens capsule is a source of essential survival factors for lens epithelial cells. Primary
Monika Damek-Poprawa et al.
Oral surgery, oral medicine, oral pathology and oral radiology, 115(2), 201-211 (2012-12-21)
Osteoradionecrosis (ORN) is common in the jaws after radiotherapy. We hypothesized that the mandible is more susceptible to ORN than the tibia, based on site disparity in hypoxic, hypocellular, and hypovascular tissue breakdown. Twelve rats received 50 Gy irradiation to
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持